AMERICAN.COM

The Journal of the American Enterprise Institute

Email this article to a friend

In general, the stalled patent reform debate pits hardware and software firms against pharma and biotech companies.

Your name (optional):

Your email address: (Required)

Send me a copy

Recipient's email address: (Required)

(separate multiple emails with commas)

Personal message (optional):

The e-mail address(es) entered on this page will only be used to send the requested article.